Abstract:Abstract Motivation Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Importantly, it has become an indispensable strategy to overcome resistance in antibiotics, antimicrobials and anticancer drugs. Facing enormous chemical space and unclear design principles for small-molecule combinations, computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery. Results We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer. First, we have developed hierarchical variational graph auto-encoders trained end-to-end to jointly embed gene–gene, gene–disease and disease–disease networks. Novel attentional pooling is introduced here for learning disease representations from associated genes’ representations. Second, targeting diseases in learned representations, we have recast the drug-combination design problem as graph-set generation and developed a deep learning-based model with novel rewards. Specifically, besides chemical validity rewards, we have introduced novel generative adversarial award, being generalized sliced Wasserstein, for chemically diverse molecules with distributions similar to known drugs. We have also designed a network principle-based reward for disease-specific drug combinations. Numerical results indicate that, compared to state-of-the-art graph embedding methods, hierarchical variational graph auto-encoder learns more informative and generalizable disease representations. Results also show that the deep generative models generate drug combinations following the principle across diseases. Case studies on four diseases show that network-principled drug combinations tend to have low toxicity. The generated drug combinations collectively cover the disease module similar to FDA-approved drug combinations and could potentially suggest novel systems pharmacology strategies. Our method allows for examining and following network-based principle or hypothesis to efficiently generate disease-specific drug combinations in a vast chemical combinatorial space. Availability and implementation https://github.com/Shen-Lab/Drug-Combo-Generator. Supplementary information Supplementary data are available at Bioinformatics online.

A Node Embedding Framework for Integration of Similarity-based Drug Combination Prediction

A Network Embedding Framework Based on Integrating Multiplex Network for Drug Combination Prediction

A Network Embedding Framework for Anticancer Drug Combination Prediction

Predicting combinations of drugs by exploiting graph embedding of heterogeneous networks

A Drug Combination Prediction Framework Based on Graph Convolutional Network and Heterogeneous Information.

A Heterogeneous Network Embedding Framework for Predicting Similarity-Based Drug-Target Interactions.

Predicting Combinative Drug Pairs Towards Realistic Screening Via Integrating Heterogeneous Features.

MTNE: A Multitext Aware Network Embedding for Predicting Drug-Drug Interaction.

Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge

MDNNSyn: A Multi-Modal Deep Learning Framework for Drug Synergy Prediction

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

Predicting drug-disease associations by network embedding and biomedical data integration.

Deep graph embedding for prioritizing synergistic anticancer drug combinations

Synergistic Multi-Drug Combination Prediction Based on Heterogeneous Network Representation Learning with Contrastive Learning

Predicting drug synergy using a network propagation inspired machine learning framework

Predicting Drug Synergy and Discovering New Drug Combinations Based on a Graph Autoencoder and Convolutional Neural Network

A Survey of Network Embedding for Drug Analysis and Prediction

Structural Network Embedding Using Multi-modal Deep Auto-encoders for Predicting Drug-drug Interactions

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection Representation.

Neighbor Communities in Drug Combination Networks Characterize Synergistic Effect.

Network-principled deep generative models for designing drug combinations as graph sets